PCSK9 inhibitors effectiveness in reducing PWV confirmed the obtained data which also suggest the possible role of PCSK9 as a promising biomarker of CV risk and as a predictor of atherosclerosis independently of menopause (50) and lipid profile (51). The gene discussed is PCSK9; the disease is atherosclerosis.